Closing Bell: Nervgen Pharma Corp down on Thursday (NGEN)

In trading today, shares of Nervgen Pharma Corp opened at $2.92 and closed at $2.87. Intraday prices ranged from $2.82 to $2.92.

The price dipped -1.71 percent from the previous day's close of $2.92.

Today across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 32,350 shares was traded during the last trading day, with total trades of 67. On average, Nervgen Pharma Corp has traded 55,458 shares over 5 days and 87,775 year-to-date.

The TSX-V market on the whole today saw 3,490 price advancers against 1,736 declines and 92 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have advanced 70.83%, while they have advanced 6.30% this year.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $204.19 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..